Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy.

Abstract

OBJECTIVE:

We examined the sarcolemma of skeletal muscle from patients with facioscapulohumeral muscular dystrophy (FSHD1A) to learn if, as in other murine and human muscular dystrophies, its organization and relationship to nearby contractile structures are altered.

METHODS:

Unfixed biopsies of control and FSHD deltoid and biceps muscles, snap-frozen at resting length, were cryosectioned, indirectly immunolabeled with fluorescent antibodies to sarcolemmal and myofibrillar markers, and examined with confocal microscopy to localize the immunolabeled proteins. Glutaraldehyde-fixed samples were stained with heavy metals, embedded, thin-sectioned, and examined with electron microscopy to determine the relationship between the sarcolemma and the underlying myofibrils.

RESULTS:

Confocal microscopy showed that some of the structures at the sarcolemma in FSHD samples were misaligned with respect to the underlying contractile apparatus. Electron microscopy showed a significant increase in the distance between the sarcolemma and the nearest myofibrils, from less than 100 nm in controls to values as high as 550 nm in FSHD.

INTERPRETATION:

Our results show that the pathophysiology of FSHD includes novel changes in the organization of the sarcolemma and its association with nearby contractile structures and suggest that, as in other muscular dystrophies, the integrity of the sarcolemma may be compromised in FSHD.

• Authors: Patrick Reed, Neil C Porter, John Strong, David W Pumplin, Andrea M Corse, Paul W Luther, Kevin M Flanigan, Robert J Bloch
• Journal: Annals of neurology (Ann Neurol) Vol. 59 Issue 2 Pg. 289-97 (Feb 2006) ISSN: 0364-5134 [Print] United States
• PMID: 16437580 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Muscle Proteins
• Spectrin

Topics

• Cytoskeleton (physiology)
• Fluorescent Antibody Technique (methods)
• Humans
• Muscle Proteins (metabolism)
• Muscle, Skeletal (metabolism, pathology, ultrastructure)
• Muscular Dystrophy, Facioscapulohumeral (pathology, physiopathology)
• Sarcolemma (metabolism, physiology, ultrastructure)
• Spectrin (metabolism)